Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.


Source link

See also  Companies are finding it’s not so simple to leave Russia; others are quietly staying put

Leave a Reply

Your email address will not be published. Required fields are marked *